The 30mg format of GHK-Cu provides an extended mass allocation designed for high-throughput in vitro cell culture, matrix remodeling assays, and longitudinal dermal model studies. This technical reference details the chemical specifications, precise reconstitution mathematics, freeze-thaw handling protocols, and analytical verification standards required for rigorous laboratory experimentation.
The 30mg format of GHK-Cu provides an extended mass allocation designed for high-throughput in vitro cell culture, matrix remodeling assays, and longitudinal dermal model studies. This technical reference details the chemical specifications, precise reconstitution mathematics, freeze-thaw handling protocols, and analytical verification standards required for rigorous laboratory experimentation.
A 30mg lyophilized vial of standard copper tripeptide contains 30 milligrams of purified Glycyl-L-histidyl-L-lysine coordinated with a divalent copper ion (Cu2+). In academic and industrial research settings, a ghk-cu 30mg mass allocation is primarily selected by investigators conducting multi-well microplate assays, organotypic skin culture systems, or high-density fibroblast exposure studies. Buying a consolidated 30mg unit minimizes lot-to-lot variance across extended experimental series while offering cost efficiencies over smaller single-assay units.
While PX1 Research maintains flexible manufacturing schedules to support custom institutional inquiries, standard catalog offerings for the GHK-Cu research peptide may vary by active production run (such as standard 20mg or 50mg presentations). Researchers requiring specific 30mg unit fills for standardized assay protocols can verify current lot availability via our complete catalog of research peptides or request tailored volumetric fills for long-term project allocations.
Glycyl-L-histidyl-L-lysine copper complex (GHK-Cu) is a naturally occurring human plasma tripeptide with a high affinity for divalent copper ions. In preclinical models, GHK-Cu functions as a signal peptide and a micronutrient carrier, regulating extracellular matrix (ECM) synthesis and cell-matrix interactions. In vitro data indicate that the complex modulates the expression of collagen types I and III, elastin, and proteoglycans, which are foundational components of connective tissue strength and elasticity.
Research in dermal fibroblast models demonstrates that GHK-Cu promotes wound closure and matrix remodeling by upregulating metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). This dual regulatory mechanism prevents excessive matrix breakdown while suppressing hyper-fibrotic scarring. Furthermore, preclinical studies suggest that GHK-Cu exhibits anti-inflammatory activity by downregulating pro-inflammatory cytokines such as TNF-alpha and IL-6, providing a stable microenvironment for tissue repair assays.
Accurate dilution calculations are critical to maintaining consistent working concentrations across cell culture microplates or microfluidic assays. Reconstituting a 30mg lyophilized cake requires introducing a measured volume of sterile, bacteriostatic water or phosphate-buffered saline (PBS). To calculate working concentrations, investigators utilize the standard formula: Concentration = Mass / Volume.
When 1.0 mL of sterile solvent is introduced into a 30mg vial, the resulting stock concentration is precisely 30.0 mg/mL (or 30.0 µg/µL). Introducing 2.0 mL yields a stock concentration of 15.0 mg/mL (15.0 µg/µL). Diluting with 3.0 mL of solvent yields a stock concentration of 10.0 mg/mL (10.0 µg/µL). For rapid experimental calculations or multi-step serial dilution protocols, researchers can utilize our automated peptide reconstitution calculator.
Lyophilized GHK-Cu displays high thermal stability when stored at -20°C in a dry, dark environment protected from moisture. However, once reconstituted into aqueous solution, the copper-peptide complex becomes susceptible to hydrolytic degradation and potential bacterial contamination over time if left unbuffered or improperly stored.
To preserve peptide integrity, reconstituted stock solutions should be divided into single-use aliquots using sterile, low-binding microcentrifuge tubes. Freeze-thaw cycles must be strictly avoided, as thermal fluctuations can cause physical shear and alter copper coordination stability. Aliquots stored at -20°C or -80°C remain stable for several months, while working solutions maintained at 4°C should be utilized within 7 to 14 days, depending on the presence of antimicrobial agents such as 0.9% benzyl alcohol.
Every batch of GHK-Cu manufactured for PX1 Research undergoes rigorous testing in an ISO 17025 accredited analytical facility. Purity verification is conducted using High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm sequence identity and molecular weight. A lot-matched lot-specific Certificate of Analysis is generated for each production run, ensuring full traceabilty and consistency across fills.
In addition to purity metrics exceeding 99.0%, every lot undergoes Chromogenic Recombinant Limulus Amebocyte Lysate (rLAL) testing to quantify bacterial endotoxins. Because endotoxins can skew cellular assays by triggering non-specific inflammatory pathways, PX1 Research enforces strict endotoxin thresholds (<0.05 EU/mg), ensuring that research compounds introduced into sensitive cell models produce reliable, reproducible data.
Choosing the appropriate vial fill size depends heavily on the scale, duration, and concentration requirements of the planned laboratory protocol. A 30mg vial presentation is ideal for high-throughput screening, multi-plate culture, or projects requiring high stock concentrations. Utilizing a single 30mg vial reduces container-closure interaction risks and saves handling time compared to opening multiple smaller 10mg vials.
Conversely, if an assay requires low working concentrations or sporadic dosing schedules across isolated test plates, smaller fill sizes (e.g., 10mg or 20mg) may be preferable to minimize the storage duration of reconstituted liquid stock. For large-scale observational studies or core laboratory facilities, high-mass options (e.g., 50mg or 100mg) or institutional wholesale accounts offer streamlined logistics and reduced packaging waste.
Within preclinical connective tissue and matrix repair research, GHK-Cu is frequently studied alongside other signaling peptides such as BPC-157 and TB-500. While all three compounds are investigated for tissue remodeling, their cellular targets and primary signaling cascades differ significantly.
GHK-Cu works primarily through gene modulation of extracellular matrix components, modulating collagen synthesis, elastin production, and MMP activity. In contrast, BPC-157 is widely studied for its pro-angiogenic activity and VEGFR2 activation in musculoskeletal models, while TB-500 (Thymosin Beta-4 fragment) focuses on actin sequestration and cell migration. Evaluating these compounds in comparative or synergistic in vitro assays allows researchers to dissect distinct stages of tissue repair and cellular migration.
Reconstitution protocols must adhere to strict aseptic techniques within a certified laminar flow hood. The outer septum of the vial should be disinfected with 70% isopropyl alcohol prior to needle insertion. Solvent should be directed down the glass wall of the vial rather than sprayed directly onto the lyophilized mass to prevent foaming and shear stress.
While standard sterile water or 0.9% sodium chloride is suitable for basic reconstitutions, researchers using stock solutions in physiological assays should consider buffer pH. GHK-Cu maintains optimal stability at near-neutral pH (6.5 to 7.5). Avoid strongly acidic solvents or strong chelating agents (such as EDTA) in the diluent, as chelation can strip the bound copper ion from the peptide framework, altering its biological activity.
In vitro models using human dermal fibroblasts have revealed that GHK-Cu plays a key role in suppressing fibrotic responses. Normal wound healing requires a balanced transition from collagen deposit to matrix reorganization. Preclinical research demonstrates that GHK-Cu downregulates Transforming Growth Factor-beta (TGF-beta) signaling when hyper-activated, thereby reducing excess collagen cross-linking associated with keloid and hypertrophic scar formation.
Furthermore, organotypic skin explant models exposed to GHK-Cu show enhanced epidermal thickness, increased glycosaminoglycan content, and restored basement membrane integrity. These findings make the compound a central candidate for assays examining tissue regeneration, anti-aging cellular pathways, and biomaterial scaffold integration. Additional research articles can be reviewed in our preclinical research library.
PX1 Research is committed to supplying high-purity, USA-manufactured research compounds for academic institutions, biotechnology companies, and independent research laboratories. Every production lot undergoes end-to-end analytical verification to confirm sequence fidelity, purity, and safety from microbial contaminants.
By maintaining strict adherence to Good Manufacturing Practices (GMP) and conducting independent ISO 17025 laboratory verification, PX1 Research eliminates supply chain uncertainty. Qualified researchers benefit from same-day dispatch on standard orders, fully documented chain-of-custody protocols, and comprehensive technical documentation for all analytical standards.
What is the concentration of a 30mg GHK-Cu vial reconstituted with 2mL of water?
Reconstituting a 30mg vial with 2.0 mL of sterile or bacteriostatic water yields a stock concentration of 15 mg/mL (15 µg/µL).
How does GHK-Cu differ from basic GHK tripeptide?
GHK-Cu includes a bound divalent copper ion (Cu2+), which is critical for its biological affinity, enzyme activation, and matrix remodeling mechanisms. Unbound GHK lacks the enzymatic coordination provided by the copper complex.
How should reconstituted GHK-Cu 30mg stock solutions be stored?
Reconstituted stock should be aliquoted into sterile, low-binding tubes to prevent freeze-thaw degradation. Aliquots stored at -20°C or -80°C remain stable for several months, while refrigerated working solutions (4°C) should be used within 7–14 days.
Where can I find the COA for my specific ghk-cu 30mg lot?
Lot-specific Certificates of Analysis (COA) detailing HPLC purity graphs, Mass Spectrometry verification, and endotoxin levels are available on our dedicated COA lookup page.
Can chelating agents like EDTA be used in the reconstitution buffer?
No. Strong chelating agents such as EDTA should be avoided, as they strip the copper ion from the GHK peptide backbone, disrupting the complex and altering experimental results.
Is GHK-Cu 30mg suitable for human administration?
No. All products supplied by PX1 Research are strictly for laboratory research, in vitro assays, and preclinical research use only. They are never for human, clinical, or veterinary administration.
What is the endotoxin limit for PX1 Research GHK-Cu lots?
PX1 Research enforces strict endotoxin thresholds (<0.05 EU/mg) verified via Chromogenic rLAL testing to prevent non-specific inflammatory artifacts in cell culture assays.
What if PX1 Research does not currently list a 30mg fill size in stock?
Standard catalog sizes may include 20mg or 50mg presentations depending on active synthesis batches. Researchers requiring 30mg configurations can contact customer support for custom fill allocations or adjust volumetric reconstitution math accordingly.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.